Scinovex
articleTop 1% cited

Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP

Neuropharmacology · 2005 · Vol. 49(7) · pp. 1053–1066
Qijiang YanMustapha RammalMichael R. TranfagliaRobert Bauchwitz
Genetics and Neurodevelopmental DisordersUbiquitin and proteasome pathwaysAutism Spectrum Disorder ResearchMetabotropic glutamate receptor 5Metabotropic glutamate receptorFragile X syndromeFMR1Metabotropic receptorMetabotropic glutamate receptor 1AntagonistKnockout mousePhenotypeAllele

MeSH terms

AgingAllelesAnimalsDrug SynergismExploratory BehaviorFemaleFragile X SyndromeGenotypeMaleMice, Inbred C57BLPhenotypePyridinesReceptors, Metabotropic GlutamateEpilepsy, ReflexMice

Funding

  • FRAXA Research Foundation
Citations
523
FWCI
13.69
field-weighted impact
References
62
Percentile
99%
vs. same field & year
Citations per year
Cited by
Trinucleotide Repeat Disorders
Annual Review of Neuroscience · 2007 · 1,372 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP · Scinovex